Reported Jan 29, 2014 · Terminated
LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00054002025.
Aidapak Services, LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Aidapak Services, LLC · 14301 Se 1st St · Vancouver, WA · 98684-3501
Is this the product you have?
- LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg), Rx only
- Distributed byAidaPak Service, LLC, NDC 00054002025
- Lot codes and dates
- LITHIUM CARBONATE ER, Tablet, 225 mg (1/2
- of 450 mg) has the following codesPedigree: AD73525_16
- EXP5/30/2014
- PedigreeAD21790_25
- EXP5/1/2014
- Amount recalled
- 400 Tablets
This recall covers 265 products
The agency filed one notice per product. You are reading one of them; the other 264 are below.
252 more are in the archive.
Where it was sold
Why it was recalled
Labeling: Label Mixup: LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg) may be potentially mislabled as one of the following drugs: CYCLOBENZAPRINE HCL, Tablet, 5 mg, NDC 00591325601, Pedigree: AD73525_7, EXP: 5/30/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD21846_11, EXP: 5/1/2014.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Aidapak Services, LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.